Cargando…
New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy
Activation of the p53 signaling pathway by DNA-damaging agents was originally proposed to result either in cell cycle checkpoint activation to promote survival or in apoptotic cell death. This model provided the impetus for numerous studies focusing on the development of p53-based cancer therapies....
Autores principales: | Mirzayans, Razmik, Andrais, Bonnie, Scott, April, Murray, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403320/ https://www.ncbi.nlm.nih.gov/pubmed/22911014 http://dx.doi.org/10.1155/2012/170325 |
Ejemplares similares
-
Role of p16(INK4A) in Replicative Senescence and DNA Damage-Induced Premature Senescence in p53-Deficient Human Cells
por: Mirzayans, Razmik, et al.
Publicado: (2012) -
Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome
por: Mirzayans, Razmik, et al.
Publicado: (2017) -
The Growing Complexity of Cancer Cell Response to DNA-Damaging Agents: Caspase 3 Mediates Cell Death or Survival?
por: Mirzayans, Razmik, et al.
Publicado: (2016) -
Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
por: Mirzayans, Razmik, et al.
Publicado: (2013) -
Roles of Polyploid/Multinucleated Giant Cancer Cells in Metastasis and Disease Relapse Following Anticancer Treatment
por: Mirzayans, Razmik, et al.
Publicado: (2018)